2016
|
Invention
|
Polyoxyethylene/polyoxypropylene copolymers and fibrinolytic inhibitors, uses thereof and composi... |
|
Invention
|
Reduced sodium poloxamer-188 formulations and methods for use. Provided is a sterile, injectable ... |
2015
|
Invention
|
Methods and compositions for improving hemostasis. Provided are methods and uses of polyoxyethyle... |
|
Invention
|
A poloxamer composition free of long circulating material and methods for production and uses the... |
|
Invention
|
Poloxamer therapy for heart failure. Provided herein uses of poloxamer 188, such as a long-circul... |
|
Invention
|
Methods and compositions for improving hemostasis.
Provided are methods and uses of polyoxyethyl... |
2014
|
Invention
|
Methods for enhancing oxygenation of jeopardized tissue.
The present invention provides methods ... |
|
Invention
|
Diuretic induced alterations of plasma volume.
Provided are uses of a poloxamer and methods of a... |
|
Invention
|
Diuretic induced alterations of plasma volume. Provided are uses of a poloxamer and methods of ad... |
|
Invention
|
Poloxamer therapy for heart failure. Provided herein are methods and uses of treating heart failu... |
2012
|
Invention
|
Methods for reducing vein irritation.
The present invention provides compositions for delivering... |
2011
|
Invention
|
Methods for enhancing oxygenation of jeopardized tissue. Methods of use of specific polyoxyethyle... |
|
Invention
|
Methods for reducing vein irritation. The present invention provides compositions for delivering ... |
2010
|
Invention
|
Compositions for delivering highly water soluble drugs. vinca alkaloids) and methods of using suc... |
2004
|
Invention
|
Anti-viral pharmaceutical compositions. The present invention provides antiviral compositions tha... |
|
Invention
|
Compositions for delivering highly water soluble drugs. The present invention provides compositio... |